A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
暂无分享,去创建一个
Niranjan Nagarajan | Andreas Wilm | Nguyet Minh Nguyen | Cameron P. Simmons | Klaus Klumpp | Martin L. Hibberd | Laura Merson | Marcel Wolbers | A. Wilm | N. Nagarajan | J. Farrar | M. Hibberd | R. Petric | L. Merson | C. Simmons | M. Wolbers | P. Aw | H. Javanbakht | K. Klumpp | Jeremy Farrar | Chau Nguyen Bich Tran | Lam Khanh Phung | Kien Thi Hue Duong | Huy le Anh Huynh | Quyen Than Ha Nguyen | Hien Tinh Tran | Chau Van Vinh Nguyen | Long Truong Hoang | Pauline P. K. Aw | Dung Thi Nguyen | Mai Phuong Pham | Truong Thanh Nguyen | Hassan Javanbakht | Janet Hammond | Rosemary Petric | Chinh Nguyen | C. Nguyen | L. Hoang | N. Nguyen | M. Pham | H. Tran | L. Phung | C. N. Tran | T. Nguyen | J. Hammond | Quyen Nguyen | Chinh Tran Nguyen | K. T. H. Duong | C. Tran | C. Nguyen
[1] K. Klumpp,et al. Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection , 2011 .
[2] J. Farrar,et al. Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam , 2011, The American journal of tropical medicine and hygiene.
[3] A. Nisalak,et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.
[4] An Adenosine Nucleoside Inhibitor of Dengue Virus , 2010 .
[5] R. Devos,et al. The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture* , 2006, Journal of Biological Chemistry.
[6] Subhash G. Vasudevan,et al. Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution , 2007, Journal of Virology.
[7] A. Nisalak,et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, Journal of Infectious Diseases.
[8] G. Dore,et al. Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo‐controlled study in patients with chronic hepatitis C , 2008, Hepatology.
[9] S. Halstead,et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. , 2009, The American journal of tropical medicine and hygiene.
[10] M. Pirisi,et al. R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus. , 2008, IDrugs : the investigational drugs journal.
[11] A. Nisalak,et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.
[12] Yen-Liang Chen,et al. Strategies for development of Dengue virus inhibitors. , 2010, Antiviral research.
[13] Sophie Yacoub,et al. The pathogenesis of dengue , 2013, Current opinion in infectious diseases.
[14] T. V. Tuan,et al. Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. , 2011, Journal of virological methods.
[15] J. Farrar,et al. A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.
[16] Niall J. Lennon,et al. The Early Whole-Blood Transcriptional Signature of Dengue Virus and Features Associated with Progression to Dengue Shock Syndrome in Vietnamese Children and Young Adults , 2010, Journal of Virology.